Artiva Biotherapeutics, Inc.
ARTVNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for ARTV. That does not mean none is planned.
Get an email about ARTV's next catalysts
Track Artiva Biotherapeutics (ARTV) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
ARTV Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.54 | FQ end Sep/2026 | Call: tbd
Market Overview
Stock performance and key metrics
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Allogeneic NK Cells | Phase 2 | Refractory Rheumatoid Arthritis (RA) | - | - |
AB-101 | Phase 2 | Non Hodgkin Lymphoma | - | - |
Refractory Rheumatoid Arthritis (RA)
1 drug in this indication
Non Hodgkin Lymphoma
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Artiva Biotherapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in Artiva Biotherapeutics, Inc.'s (ARTV) pipeline across Phase 2. Its lead program is AB-101 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Artiva Biotherapeutics, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Artiva Biotherapeutics, Inc. (ARTV) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track ARTV biotech catalysts?→
Add ARTV to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Artiva Biotherapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.